Skip to content
1887

Abstract

The increasing prevalence of tigecycline and carbapenem-resistant (CRKP) poses a serious challenge, especially in resource-limited settings. Its ability to exchange resistance genes with other bacteria accelerates the spread of multidrug resistance. While carbapenems and tetracyclines have been used effectively against , resistance to these agents is now rising globally, narrowing available treatment options.

The study aimed to determine the phenotypic and genotypic prevalence of carbapenem and tetracycline resistance in isolates along with the transferability pattern of carbapenem and tetracycline resistance genes in these isolates.

Clinical isolates from pus and respiratory samples were identified using biochemical tests and MALDI-TOF MS. Antimicrobial susceptibility test was performed by the Kirby–Bauer disc diffusion method, and MICs were determined by the broth microdilution test method. PCR was performed to detect carbapenemase ( , and ) and tetracycline resistance genes [, , , and ], followed by Sanger sequencing for validation. Conjugation assays assessed gene transferability.

Out of 152 CRKP isolates, 20.4% (31 out of 152) were found to be resistant to tigecycline. All tigecycline-resistant isolates exhibited complete resistance (31 out of 31; 100%) to ceftazidime, ciprofloxacin and omadacycline. Additionally, resistance to amikacin and cefoperazone-sulbactam was observed in 87.1% (27 out of 31) and 77.4% (24 out of 31) of the isolates. Resistance to minocycline and colistin was detected in 51.6% (16 out of 31) and 29.0% (9 out of 31) of the isolates, respectively.

PCR analysis revealed that 51.6% (16 out of 31) of the isolates carried the gene, and 29.0% (9 out of 31) carried the gene. None of the isolates harboured the gene. With respect to tetracycline resistance determinants, the gene was detected in 12.9% (4 out of 31) of the isolates, and the ) gene in 3.2% (1 out of 31), while , , and were not detected in any isolate.

Conjugation assays demonstrated that plasmids carrying and were transferable to a recipient strain, indicating their potential for horizontal gene transfer. In contrast, plasmids harbouring and genes were not transferable under the experimental conditions.

Tigecycline-resistant isolates showed high multidrug resistance, with transferable and genes. In contrast, chromosome and plasmid-borne tetracycline resistance genes and were non-transferable, indicating limited horizontal spread.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.001017.v4
2026-03-12
2026-04-10

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/acmi/8/3/acmi001017.v4.html?itemId=/content/journal/acmi/10.1099/acmi.0.001017.v4&mimeType=html&fmt=ahah

References

  1. Yu R, Li L, Zou C, Chen Z, Schwarz S et al. Emergence of high-level tigecycline resistance due to the amplification of a tet(A) gene variant in clinical carbapenem-resistant Klebsiella pneumoniae. Clin Microbiol Infect 2023; 29:1452 [View Article] [PubMed]
    [Google Scholar]
  2. Pathak A, Tejan N, Dubey A, Chauhan R, Fatima N et al. Outbreak of colistin resistant, carbapenemase (blaNDM, blaOXA-232) producing Klebsiella pneumoniae causing blood stream infection among neonates at a tertiary care hospital in India. Front Cell Infect Microbiol 2023; 13: [View Article]
    [Google Scholar]
  3. Bray AS, Zafar MA. Deciphering the gastrointestinal carriage of Klebsiella pneumoniae. Infect Immun 2024; 92:e0048223 [View Article] [PubMed]
    [Google Scholar]
  4. Li D, Huang X, Rao H, Yu H, Long S et al. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol 2023; 13:1157010 [View Article] [PubMed]
    [Google Scholar]
  5. Alhazmi AH, Alameer KM, Abuageelah BM, Alharbi RH, Mobarki M et al. Epidemiology and antimicrobial resistance patterns of urinary tract infections: a cross-sectional study from southwestern Saudi Arabia. Medicina (Kaunas) 2023; 59:1411 [View Article] [PubMed]
    [Google Scholar]
  6. Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM et al. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature. Drug Resist Updat 2018; 40:25–39 [View Article] [PubMed]
    [Google Scholar]
  7. Ashurst JV, Dawson A. Klebsiella Pneumonia. In StatPearls Treasure Island (FL): StatPearls Publishing; 2025 https://www.ncbi.nlm.nih.gov/books/NBK519004/
    [Google Scholar]
  8. Chiu S, Chan M, Huang L, Lin Y, Lin J et al. Tigecycline resistance among carbapenem-resistant Klebsiella pneumoniae: clinical characteristics and expression levels of efflux pump genes. PLoS ONE 2017; 12:e0175140 [View Article] [PubMed]
    [Google Scholar]
  9. Connell SR, Tracz DM, Nierhaus KH, Taylor DE. Ribosomal protection proteins and their mechanism oftetracyclineresistance. Antimicrob Agents Chemother 2003; 47:3675–3681 [View Article]
    [Google Scholar]
  10. Xu J, Zhu Z, Chen Y, Wang W, He F. The Plasmid-Borne tet(A) gene is an important factor causing tigecycline resistance in ST11 carbapenem-resistant Klebsiella pneumoniae under selective pressure. Front Microbiol 2021; 12:644949 [View Article]
    [Google Scholar]
  11. Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 2005; 245:195–203 [View Article] [PubMed]
    [Google Scholar]
  12. Yao H, Cheng J, Li A, Yu R, Zhao W et al. Molecular characterization of an IncFIIk Plasmid co-harboring blaIMP–26 and tet(A) variant in a clinical Klebsiella pneumoniae isolate. Front Microbiol 2020; 11:11 [View Article]
    [Google Scholar]
  13. Zhang S, Wen J, Wang Y, Wang M, Jia R et al. Dissemination and prevalence of plasmid-mediated high-level tigecycline resistance gene tet (X4). Front Microbiol 2022; 13:13 [View Article]
    [Google Scholar]
  14. Haji SH, Aka STH, Ali FA. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. PLoS One 2021; 16:e0259005 [View Article] [PubMed]
    [Google Scholar]
  15. Govindaswamy A, Bajpai V, Khurana S, Batra P, Mathur P et al. Prevalence and characterization of carbapenemase-producing Escherichia coli from a tertiary care hospital in India. J Glob Infect Dis 2019; 11:123–124 [View Article] [PubMed]
    [Google Scholar]
  16. Jaggi N, Chatterjee N, Singh V, Giri SK, Dwivedi P et al. Carbapenem resistance in Escherichia coli and Klebsiella pneumoniae among Indian and international patients in North India. Acta Microbiol Immunol Hung 2019; 66:367–376 [View Article] [PubMed]
    [Google Scholar]
  17. Ng LK, Martin I, Alfa M, Mulvey M. Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes 2001; 15:209–215 [View Article] [PubMed]
    [Google Scholar]
  18. Singh S, Pathak A, Kumar A, Rahman M, Singh A et al. Emergence of chromosome-borne colistin resistance gene mcr-1 in clinical isolates of Klebsiella pneumoniae from India. Antimicrob Agents Chemother 2018; 62:e01885–20 [View Article]
    [Google Scholar]
  19. Singh S, Pathak A, Rahman M, Singh A, Nag S et al. Genetic characterisation of colistin resistant Klebsiella pneumoniae clinical isolates from North India. Front Cell Infect Microbiol 2021; 11:666030 [View Article] [PubMed]
    [Google Scholar]
  20. Clinical and laboratory standards institute (CLSI) performance standards for antimicrobial susceptibility testing. In CLSI Supplement M100, 35ed. edn Wayne, PA: CLSI; 2023
    [Google Scholar]
  21. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint tables for interpretation of mics and zone diameters; 2023 https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.1_Breakpoint_Tables.pdf
  22. Cruz DL. n.d. Resources and protocol, conjugation (on solid surfaces). OpenWetWare https://openwetware.org/wiki/conjugation
    [Google Scholar]
  23. Ni W, Han Y, Liu J, Wei C, Zhao J et al. Tigecycline treatment for carbapenem-resistant enterobacteriaceae infections: a systematic review and meta-analysis. Medicine (Baltimore) 2016; 95:e3126 [View Article] [PubMed]
    [Google Scholar]
  24. Jyoti N, Sahu C, Sinha R, Pathak A, Verghese G. Tigecycline resistant pattern among carbapenem resistant gram-negative bacilli: prospective cross-sectional study. S Asian J Res Microbiol 2024; 18:21–29 [View Article]
    [Google Scholar]
  25. Sun C, Yu Y, Hua X. Resistance mechanisms of tigecycline in Acinetobacter baumannii. Front Cell Infect Microbiol 2023; 13:1141490 [View Article]
    [Google Scholar]
  26. Behera B, Das A, Mathur P, Kapil A, Gadepalli R et al. Tigecycline susceptibility report from an Indian tertiary care hospital. Indian J Med Res 2009; 129:446–450 [PubMed]
    [Google Scholar]
  27. Hoban DJ, Bouchillon SK, Hawser SP, Badal RE. Trends in the frequency of multiple drug-resistant enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the study for monitoring antimicrobial resistance trends 2002 to 2007. Diagn Microbiol Infect Dis 2010; 66:78–86 [View Article] [PubMed]
    [Google Scholar]
  28. Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob 2020; 19:1 [View Article] [PubMed]
    [Google Scholar]
  29. Ahmed S, Rahman MS, Hasan MM, Paul N, Sajib AA. Microbial degradation of lignocellulosic biomass: discovery of novel natural lignocellulolytic bacteria. BioTechnologia 2018; 99:137–146 [View Article]
    [Google Scholar]
  30. Nagaraj G, Shamanna V, Govindan V, Rose S, Sravani D et al. NIHR global health research unit on genomic surveillance of antimicrobial resistance. High-resolution genomic profiling of carbapenem-resistant Klebsiella pneumoniae isolates: a multicentric retrospective Indian study. Clin Infect Dis 2021; 73:S300–S307 [View Article]
    [Google Scholar]
  31. Guo Y, Han R, Jiang B, Ding L, Yang F et al. In Vitro activity of new β-Lactam–β-Lactamase inhibitor combinations and comparators against clinical isolates of gram-negative bacilli: results from the China Antimicrobial Surveillance Network (CHINET) in 2019. Microbiol Spectr 2022; 10: [View Article]
    [Google Scholar]
  32. Araj GF, Ibrahim GY. Tigecycline in vitro activity against commonly encountered multidrug-resistant gram-negative pathogens in a Middle Eastern country. Diagn Microbiol Infect Dis 2008; 62:411–415 [View Article] [PubMed]
    [Google Scholar]
  33. Tang B, Yang H, Jia X, Feng Y. Coexistence and characterization of Tet(X5) and NDM-3 in the MDR-Acinetobacter indicus of duck origin. Microb Pathog 2021; 150:104697 [View Article] [PubMed]
    [Google Scholar]
  34. Shafiq M, Zeng M, Permana B, Bilal H, Huang J et al. Coexistence of blaNDM–5 and tet(X4) in international high-risk Escherichia coli clone ST648 of human origin in China. Front Microbiol 2022; 13:13 [View Article]
    [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.001017.v4
Loading
/content/journal/acmi/10.1099/acmi.0.001017.v4
Loading

Data & Media loading...

Supplements

Supplementary material 1

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error